Baltimore Secures $152 Million in Opioid Settlement, Enhancing City’s Fight Against Drug Crisis

Baltimore, Maryland, has opted to accept a $152 million settlement from two drug distributors as part of its ongoing efforts to combat the devastating effects of the opioid crisis, a decision that signifies a pragmatic move in light of a complex legal landscape. This amount represents slightly less than the jury’s initial verdict of $266 million delivered late last year, but it contributes to the city’s total recovery of $579.8 million from pharmaceutical companies. The initial jury award came after an extensive seven-week trial against McKesson and AmerisourceBergen, which concluded in 2022. However, Baltimore City … Read more

Opioid Settlement: Baltimore Secures $152 Million Jury Award, Aims for Healing and Recovery

BALTIMORE — The city of Baltimore will accept a $152 million jury award in its ongoing litigation against opioid distributors, a significant outcome in the battle against the opioid crisis that has devastated communities across the nation. The jury found that the companies failed to monitor suspicious orders of painkillers, contributing to widespread addiction and overdose deaths. The award follows a lengthy trial that exposed how these distributors prioritized profits over public health, exacerbating one of the deadliest drug crises in U.S. history. This ruling is part of a larger trend where cities and states … Read more

Baltimore Secures $152.3 Million Settlement in Landmark Opioid Case Against Major Distributors

BALTIMORE — Mayor Brandon Scott announced Thursday that Baltimore City has agreed to a reduced settlement in its ongoing litigation against opioid distributors McKesson and Cencora, previously known as AmerisourceBergen. This decision follows a jury’s initial award of $266 million last fall, which a judge deemed excessive and subsequently cut down. With the acceptance of this revised settlement amount, Baltimore now adds $152.3 million to its efforts to hold pharmaceutical giants accountable for their role in the opioid crisis that has severely impacted the city. “From the beginning, this case has always been about securing … Read more

Justice Served: Baltimore City Secures $152 Million to Combat Opioid Crisis Amid Ongoing Challenges

Baltimore, Maryland, has agreed to a $152 million jury award stemming from litigation against two pharmaceutical companies, McKesson and AmerisourceBergen. This development is part of a broader legal battle concerning the companies’ roles in the city’s escalating opioid crisis. Initially, a jury in 2024 awarded the city a staggering $266 million following a seven-week trial. However, in June 2025, a judge instructed city leaders that they would have to choose between a reduced settlement of $52 million or returning to trial after deeming the original amount excessive. The city will now also receive an additional … Read more